Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Post by sollmgon Feb 08, 2024 1:33pm
136 Views
Post# 35870466

QIPT Financial Forecast - Annual -2024/2027

QIPT Financial Forecast - Annual -2024/2027

Financial Forecast

Revenue This Year
270.96M
Increased by22.20%
Revenue Next Year
293.79M
Increased by8.43%
EPS This Year
-0.00
EPS Next Year
0.13
Year 2019 2020 2021 2022 2023 2024 2025 2026 2027
Revenue
80.97M 72.64M 102.35M 139.86M 221.74M 270.96M 293.79M 440.89M 529.86M
Revenue Growth
- -10.29% 40.90% 36.65% 58.54% 22.20% 8.43% 50.07% 20.18%
EPS
-0.36 -0.20 -0.20 0.13 -0.07 -0.00 0.13 0.97 1.49
EPS Growth
- - - - - - - 647.29% 53.64%
No. Analysts - - - - - 9 7 3 3

<< Previous
Bullboard Posts
Next >>